Article
CRISPR-SID: identifying EZH2 as a druggable target for desmoid tumors via <i>in vivo</i> dependency mapping
2019-04-01
Abstract excerpt
Cancer precision medicine implies identification of tumor-specific vulnerabilities associated with defined oncogenic pathways. Desmoid tumors are soft-tissue neoplasms strictly driven by Wnt signaling network hyperactivation. Despite this clearly defined genetic etiology and the strict and unique implication of the Wnt/β-catenin pathway, no specific molecular targets for these tumors have been identified. To addre...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2415c980-060f-5d3a-912b-487f5bddb181
- DOI
- 10.1101/595769
